“pharmaceuticals” Archives

Entry Author Date Location
Tigerlabs Health Accelerator to Pair Corporate Needs with Startups 04/17/13 New York
Newark Mayor Cory Booker Says Government Must Embrace Tech, Be Open Source 03/20/13 New York
NYU to Train Data Scientists for E-Commerce, Pharma, and Other Markets 02/20/13 New York
Merck on Track to Seek Approval for Two Heart Drugs in ’13 08/27/12 New York
San Diego Life Sciences Roundup: Aragon, Illumina, CareFusion, & More 03/08/12 San Diego
The Thinking Behind Domain’s $760M Life Sciences Deal in Russia 03/07/12 San Diego
FDA vs. Drug Ads: Cut the Kids and Dogs, Spell Out Side Effects 02/06/12 National
Jury Convicts Financial Advisor in Murder of Life Sciences Investor 11/22/11 San Diego
Turnaround CEO Shores Up Strategy for Unigene Based on Big Pharma Partnerships 11/15/11 New York
Genzyme MS Drug Significantly Reduces Relapse, Disability in Late-Stage Trial 11/14/11 Boston
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes 11/10/11 New York
NPS Charts Positive Results on Parathyroid Drug 11/07/11 New York
AMAG Shares Zoom on CEO Departure and Re-Org Plans 11/04/11 Boston
NPS Pharma’s Not-So-Excellent Wall Street Adventure 11/03/11 New York
Pacira Wins FDA Approval of Pain Drug, Cushioning Pain of 3Q Loss 10/31/11 New York
Xconomist of the Week: Appature’s Kabir Shahani Eyes Culture as Company Expands 10/14/11 Seattle
The Essential Steve Jobs for Today’s Pharmaceutical Executive 10/06/11 New York
J&J Honors Genentech Scientist, Holds Meeting on Future of Anti-Angiogenesis Drugs 09/15/11 New York
Shire Wins Approval for Rare-Disease Drug Developed At Boston-Based Unit 08/25/11 Boston
Regeneron Shares Fall on FDA Delay 08/17/11 New York
Pfizer Wins Viagra Patent Case 08/15/11 New York
Pulmatrix Wins $14M to Back Drug For Cystic Fibrosis And Other Lung Ailments 08/15/11 Boston
Xconomist of the Week: Five Questions About Life Sciences Investing for Dennis Purcell of Aisling Capital 08/04/11 New York
Ventrus Attracts Investors With Hemorrhoid Drug and Two Other Late-Stage Drug Candidates 08/02/11 New York
IPO Activity Returns to Pre-Recession Levels in Second Quarter 07/26/11 National
Amag Makes Good on Acquisition Promise, But Wall Street Balks 07/20/11 Boston
Pfizer buys Icagen 07/20/11 New York
Coronado Biosciences Files Form 10 07/18/11 New York
Organovo’s Bio-Printing Technology Yields Unanticipated Revenue from Pharma Partners 07/13/11 San Diego
Amag Rebounds from FDA Handwringing, Looks To Stock Pipeline Through Acquisitions 07/12/11 Boston
Page 2 of 6 « previous page · next page »